Bioanalytical Method Validation: History, Process, and Regulatory Perspectives - Bioanalysis 2020

Patrick Faustino, CDER Office of Pharmaceutical Quality (OPQ), provides context for bioanalysis; explains the Bioanalytical Method Validation (BMV) guidance, history, process and procedures; and shares a foundational understanding of the importance of BMV.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cdersbia
CDER SBIA 2020 Playlist: • 2020 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cderbsbialearn
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.gov/subscriptionm...
Email: [e-mail]
Phone: [phone] I [phone]